Featured Topics
Lead story
Other featured articles
-
Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?
Lack of awareness remains one of the biggest barriers to participation in Alzheimer’s disease clinical trials, especially among underrepresented groups. New ways to connect with communities and to expand access to clinical trials include a virtual Alzheimer’s disease informational series, which reveals important insights about how people engage with virtual content differently than at in-person events.
Posted in -
COVID-19’s Total Cost to the U.S. Economy Will Reach $14 Trillion by End of 2023
Workplace absences, along with sales lost due to the cessation of brick-and-mortar retail shopping, airline travel and public gatherings, contributed the most.
Posted in -
Should the Government Restrict Direct-to-Consumer Prescription Drug Advertising? Six Takeaways on their Effects.Â
Policymakers should proceed with caution as they design proposals to restrict advertising. Â
Posted in -
Why the Vaccine Guidelines Work Against Blacks
By making COVID vaccine eligibility based on age, Black communities were left out despite making up a larger portion of COVID-19 deaths and infections.
Posted in
About this section
The Evidence Base focuses on improving policy in health, economics, and well-being. Learn More>
View all of the contributors to The Evidence Base here.
More from the Blog
-
Tackling the Opioid Crisis with Compassion, New Ways to Reduce Use and Treatment
This piece explains how we arrived at the current opioid crisis, policies that have been tried thus far, and options to address the crisis moving forward.
Categorized in -
Encouraging Integrative, Non-Opioid Approaches To Pain: A Policy Agenda
Big changes are necessary to overcome our myopic view favoring immediate pain relief over safer approaches that are effective in the long term.
Categorized in